Interpace Biosciences, Inc (IDXG)

CIK 1054102 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Interpace Biosciences, Inc.

Recent SEC filings

FiledFormAccession number
Nov 5, 20268-A12B0001493152-26-050057
Nov 5, 2026CERT0001354457-26-001055
Oct 30, 2026S-1/A0001493152-26-049456
Oct 15, 20268-K0001493152-26-047090
Oct 15, 2026FWP0001493152-26-047185
Oct 1, 2026S-1/A0001493152-26-045187
Sep 25, 2026S-10001493152-26-044208
Sep 17, 2026S-80001493152-26-043106
Aug 27, 20268-K0001493152-26-040329
Aug 26, 20268-K/A0001493152-26-040182
Aug 21, 20268-K0001493152-26-039530
Aug 20, 202640001493152-26-039528
Aug 20, 202640001493152-26-039504
Aug 20, 202640001493152-26-039495
Aug 20, 202640001493152-26-039505
Aug 20, 202640001493152-26-039507
Aug 20, 202640001493152-26-039496
Aug 12, 20268-K0001493152-26-037360
Aug 10, 202610-Q0001493152-26-036895
Jul 7, 2026DEF 14A0001493152-26-032369
Jul 7, 2026DEFA14A0001493152-26-032377
Jun 25, 2026PREM14A0001493152-26-029987
Jun 23, 2026PRE 14A0001493152-26-029801
May 14, 20268-K0001493152-26-023095
May 12, 202610-Q0001493152-26-022508